Teladoc Health, Inc.

Teladoc Health, Inc.

8.51
USD
-0.22
(-2.52%)
-0.86EPS
1.06BMarket Cap
Feb 23Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.13
0.29
3.89
2.91
4.21
6.35
7.7
12.09
12.95
14.91
16.05
15.07
14.36
13.71
Basic EPS, GAAP
-0.06
-0.13
-2.91
-1.75
-1.93
-1.47
-1.38
-5.36
-2.73
-84.6
-1.36
-5.87
-1.14
-0.86
Free Cash Flow per Basic Share
-0.05
-0.09
-2.76
-1.31
-0.72
-0.2
0.26
-0.83
0.88
1.17
2.16
1.72
1.5
1.49
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-1.47
-1.81
4.64
5
9.08
14.37
13.94
105.69
99.99
14.17
13.96
8.6
7.77
7.1
Tangible Book Value per Share
-2.03
-2.81
2.78
0.39
-1.62
0.4
0.58
-4.78
-2.3
-3.7
-2.55
-1.29
-1.09
-0.58
Basic Weighted Avg Shares
152
152
20
42
55
66
72
91
157
161
162
171
176
180
Sales/Revenue/Turnover
20
44
77
123
233
418
553
1,094
2,033
2,407
2,602
2,570
2,530
2,468
Operating Margin (%)
-29.48
-34.35
-71.38
-45.23
-26.66
-15.78
-13.34
-38.23
-11.76
-9.45
-8.09
-8.13
-6.46
-5.36
Depreciation Expense
1
2
5
8
19
36
45
78
220
268
349
383
376
378
Net Income, GAAP
-6
-17
-58
-74
-107
-97
-99
-485
-429
-13,660
-220
-1,001
-200
-155
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-30.24
-39.14
-74.98
-60.26
-45.77
-23.23
-17.87
-44.35
-21.09
-567.53
-8.47
-38.97
-7.92
-6.27
Working Capital
2
44
134
62
116
470
498
727
894
916
1,068
722
714
-189
LT Debt
3
25
25
42
207
415
465
1,423
1,267
1,573
1,582
1,024
1,029
28
Total Equity
19
53
179
231
559
1,013
1,014
15,884
16,046
2,308
2,326
1,491
1,386
1,295
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
-36.25
-27.04
-12.35
-9.75
-5.74
-2.69
-148.85
-9.51
-52.46
-13.93
-11.52

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
11
1,007
1,007
LT Borrowings
996
- -
- -
LT Finance Leases
32
30
28
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
180
182
182
Market Capitalization
983
1,540
1,057

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,132
1,148
1,226
Cash, Cash Equivalents & STI
751
774
850
Accounts Receivable, Net
214
221
231
Inventories
32
29
31
Total Current Liabilities
405
1,382
1,416
Payables & Accruals
227
218
225
ST Debt
11
1,007
1,007
Deferred Revenue
66
61
62

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
159.24%
-25.36%
-7.07%
Free Cash Flow
-102.31%
-37.59%
-9.84%
Net Income, GAAP
370.52%
649.99%
-79.99%
Sales/Revenue/Turnover
46.74%
21.91%
-1.54%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
646
642
641
640
2,570
2025
629
632
626
642
2,530
2026
614
607
605
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.49
-4.92
-0.19
-0.28
-5.87
2025
-0.53
-0.19
-0.28
-0.14
-1.14
2026
-0.36
-0.21
-0.15
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Charles Divita
Full Time Employees
5,600
Sector
Health services
Industry
Medical/Nursing services
Address
155 E 44th Street New York NY United States 10017
IPO Date
Jul 1, 2015
Business
Teladoc Health, Inc. delivers a broad spectrum of virtual healthcare solutions across the United States and internationally. The company offers a comprehensive portfolio spanning from routine, acute, and chronic medical challenges to intricate health conditions, encompassing areas such as diabetes management, hypertension, renal issues, oncology, heart failure, and diverse mental well-being services. Its offerings include primary care and specialized telehealth consultations, sophisticated chronic disease management programs, expert medical second opinions, dedicated mental health support, and robust platform services. Serving a wide client base, Teladoc Health partners with employers, health plans, hospital networks, and financial services firms, alongside individual members. The company markets its products and services under prominent brands like Teladoc, Livongo, and BetterHelp. Established in 2002, the firm is headquartered in Purchase, New York. Recent strategic initiatives include the acquisition of Uplift in April 2025 to expand mental health offerings with in-network health plans, and the launch of a next-generation Cardiometabolic Health Program.

Company News

  • Teladoc Soars 26% as Revenue and Profit Beat Estimates; Hims & Hers Health and American Well Tick Up

  • Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook

  • Teladoc Health, Inc. (TDOC) Q3 2026 Earnings Call Transcript

  • Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.

  • Teladoc Health Q3 Earnings Call Highlights

  • Teladoc: 3 Key Takeaways for Long-Term Investors

  • Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

  • Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates

  • Teladoc Health Reports Third Quarter 2026 Results

  • Unveiling Teladoc (TDOC) Q3 Outlook: Wall Street Estimates for Key Metrics

  • Teladoc (TDOC) Outperforms Broader Market: What You Need to Know

  • Teladoc Health, Inc. $TDOC Shares Acquired by Counterpoint Mutual Funds LLC

  • Teladoc Health to Announce Third Quarter 2026 Financial Results

  • Teladoc (TDOC) Rises As Market Takes a Dip: Key Facts

  • Analyzing Teladoc Health (NYSE:TDOC) & Schrodinger (NASDAQ:SDGR)

  • Teladoc Strengthens Solo Platform With New AI-Powered Care Tools

  • Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

  • Stock Picks From Seeking Alpha's September 2026 New Analysts

  • Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery

  • Head to Head Survey: National Research (NASDAQ:NRC) vs. Teladoc Health (NYSE:TDOC)